MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,310,335 | +1168012.5% | 136,403 | +787.9% | 0.00% | – |
| Q1 2023 | $369 | -99.9% | 15,363 | -33.5% | 0.00% | – |
| Q1 2022 | $509,000 | -33.3% | 23,115 | -51.7% | 0.00% | – |
| Q4 2021 | $763,000 | -71.1% | 47,861 | -63.9% | 0.00% | -100.0% |
| Q3 2021 | $2,641,000 | +239.5% | 132,586 | +194.8% | 0.00% | – |
| Q2 2021 | $778,000 | -52.6% | 44,971 | -45.7% | 0.00% | -100.0% |
| Q1 2021 | $1,642,000 | -66.0% | 82,842 | -70.1% | 0.00% | -66.7% |
| Q4 2020 | $4,834,000 | +18.9% | 276,875 | +31.2% | 0.00% | -40.0% |
| Q3 2020 | $4,067,000 | +1827.5% | 211,079 | +1847.6% | 0.01% | – |
| Q2 2020 | $211,000 | -84.2% | 10,838 | -88.6% | 0.00% | -100.0% |
| Q1 2020 | $1,334,000 | +144.3% | 95,297 | +327.9% | 0.00% | +200.0% |
| Q4 2019 | $546,000 | -56.7% | 22,271 | -82.2% | 0.00% | -50.0% |
| Q3 2019 | $1,261,000 | – | 125,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |